These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

860 related items for PubMed ID: 23726124

  • 1. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC, Vanderkerken MA, Verstraete KL.
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [Abstract] [Full Text] [Related]

  • 2. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
    Kloth JK, Hillengass J, Listl K, Kilk K, Hielscher T, Landgren O, Delorme S, Goldschmidt H, Kauczor HU, Weber MA.
    Int J Cancer; 2014 Nov 15; 135(10):2380-6. PubMed ID: 24706394
    [Abstract] [Full Text] [Related]

  • 3. Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation.
    Hillengass J, Zechmann C, Bäuerle T, Wagner-Gund B, Heiss C, Benner A, Ho A, Neben K, Hose D, Kauczor HU, Goldschmidt H, Delorme S, Moehler T.
    Clin Cancer Res; 2009 May 01; 15(9):3118-25. PubMed ID: 19366830
    [Abstract] [Full Text] [Related]

  • 4. Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.
    Hillengass J, Wasser K, Delorme S, Kiessling F, Zechmann C, Benner A, Kauczor HU, Ho AD, Goldschmidt H, Moehler TM.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):475-81. PubMed ID: 17255268
    [Abstract] [Full Text] [Related]

  • 5. DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approach.
    Jamet B, Necib H, Carlier T, Frampas E, Bazin J, Desfontis PH, Monnet A, Bodet-Milin C, Moreau P, Touzeau C, Kraeber-Bodere F.
    Cancer Imaging; 2024 Jul 11; 24(1):93. PubMed ID: 38992707
    [Abstract] [Full Text] [Related]

  • 6. [MR-Imaging of lower leg muscle perfusion].
    Leppek R, Hoos O, Sattler A, Kohle S, Azzam S, Al Haffar I, Keil B, Ricken P, Klose KJ, Alfke H.
    Herz; 2004 Feb 11; 29(1):32-46. PubMed ID: 14968340
    [Abstract] [Full Text] [Related]

  • 7. Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging.
    Bäuerle T, Hillengass J, Fechtner K, Zechmann CM, Grenacher L, Moehler TM, Christiane H, Wagner-Gund B, Neben K, Kauczor HU, Goldschmidt H, Delorme S.
    Radiology; 2009 Aug 11; 252(2):477-85. PubMed ID: 19703885
    [Abstract] [Full Text] [Related]

  • 8. Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma.
    Hillengass J, Ritsch J, Merz M, Wagner B, Kunz C, Hielscher T, Laue H, Bäuerle T, Zechmann CM, Ho AD, Schlemmer HP, Goldschmidt H, Moehler TM, Delorme S.
    Br J Haematol; 2016 Jul 11; 174(1):127-35. PubMed ID: 26991959
    [Abstract] [Full Text] [Related]

  • 9. Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma.
    Dutoit JC, Claus E, Offner F, Noens L, Delanghe J, Verstraete KL.
    Eur J Radiol; 2016 Feb 11; 85(2):373-82. PubMed ID: 26781143
    [Abstract] [Full Text] [Related]

  • 10. Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma).
    Van Den Berghe T, Verstraete KL, Lecouvet FE, Lejoly M, Dutoit J.
    Skeletal Radiol; 2022 Jan 11; 51(1):101-122. PubMed ID: 34523007
    [Abstract] [Full Text] [Related]

  • 11. Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging.
    Lin C, Luciani A, Belhadj K, Deux JF, Kuhnowski F, Maatouk M, Beaussart P, Cuenod CA, Haioun C, Rahmouni A.
    Radiology; 2010 Feb 11; 254(2):521-31. PubMed ID: 20093523
    [Abstract] [Full Text] [Related]

  • 12. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA, Cutajar M, Gordon I.
    Eur J Radiol; 2009 Sep 11; 71(3):576-81. PubMed ID: 19004588
    [Abstract] [Full Text] [Related]

  • 13. Dynamic contrast-enhanced magnetic resonance imaging parameters correlate with advanced revised-ISS and angiopoietin-1/angiopoietin-2 ratio in patients with multiple myeloma.
    Terpos E, Matsaridis D, Koutoulidis V, Zagouri F, Christoulas D, Fontara S, Panourgias E, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Moulopoulos LA.
    Ann Hematol; 2017 Oct 11; 96(10):1707-1714. PubMed ID: 28766001
    [Abstract] [Full Text] [Related]

  • 14. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP, Kramer H, Reiser MF, Glaser C.
    Top Magn Reson Imaging; 2007 Jun 11; 18(3):193-202. PubMed ID: 17762383
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity.
    Jiang H, Wang Z, Xian J, Li J, Chen Q, Ai L.
    Acta Radiol; 2012 Feb 01; 53(1):87-94. PubMed ID: 22184678
    [Abstract] [Full Text] [Related]

  • 16. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
    Myslivecek M, Nekula J, Bacovsky J, Scudla V, Koranda P, Kaminek M.
    Nucl Med Rev Cent East Eur; 2008 Feb 01; 11(1):12-6. PubMed ID: 19173182
    [Abstract] [Full Text] [Related]

  • 17. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
    Barile A, Sabatini M, Iannessi F, Di Cesare E, Splendiani A, Calvisi V, Masciocchi C.
    Radiol Med; 2004 Apr 01; 107(4):356-66. PubMed ID: 15103287
    [Abstract] [Full Text] [Related]

  • 18. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y.
    J Magn Reson Imaging; 2009 Feb 01; 29(2):341-9. PubMed ID: 19161186
    [Abstract] [Full Text] [Related]

  • 19. Whole-body MRI for the staging and follow-up of patients with metastasis.
    Schmidt GP, Reiser MF, Baur-Melnyk A.
    Eur J Radiol; 2009 Jun 01; 70(3):393-400. PubMed ID: 19457631
    [Abstract] [Full Text] [Related]

  • 20. [Does dynamic contrast-enhanced MRI enable recognition of development of vertebral fractures in multiple myeloma?].
    Scherer A, Wittsack HJ, Engelbrecht V, Strupp C, Poll LW, Willers R, Schneider P, Gattermann N, Haas R, Mödder U.
    Rofo; 2002 Aug 01; 174(8):984-90. PubMed ID: 12142975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.